Skip to main content

Research Repository

Advanced Search

Zinc-modified nanotransporter of anticancer drugs for targeted therapy: biophysical analysis.

Skalickova, Sylvie; Docekalova, Michaela; Stankova, Martina; Uhlirova, Dagmar; Ruttkay-Nedecky, Branislav; Fernandez, Carlos; Kepinska, Marta; Milnerowicz, Halina; Kizek, Rene

Authors

Sylvie Skalickova

Michaela Docekalova

Martina Stankova

Dagmar Uhlirova

Branislav Ruttkay-Nedecky

Marta Kepinska

Halina Milnerowicz

Rene Kizek



Abstract

Modern anticancer therapy aims to increase the effectiveness of tumor treatment. The aim of this work was to propose a new nanotransporter for targeted delivery of anthracycline antibiotics, which is characterized by its bioavailability, increased uptake of the drug from the bloodstream at the site of tumor tissue and as well as low toxicity to non-target tissue. Chitosan nanoparticles have attracted great attention in the field of drug delivery due to their stability, low toxicity and easy preparation. Deacetylated chitosan skeleton is composed of glucosamine units and has a high density of charged amino groups which allow strong electrostatic interactions with biomolecules, transition metals (Zn, Se) and peptides. We obtained the encapsulation effectiveness of chitosan 20%. Electrochemical detection of the bounded Zn2+ ions into the chitosan structure showed shift from -0.99 to -0.93 V. This result proved the formation of a chitosan-zinc complex. The ability of metallothione in to quench the 2,2-diphenyl-1-picrylhydrazylradicalin the presence of 50 {aelig}M doxorubicin was confirmed by the change of relative absorbance in the range of 50 to 60%.

Citation

SKALICKOVA, S., DOCEKALOVA, M., STANKOVA, M., UHLIROVA, D., RUTTKAY-NEDECKY, B., FERNANDEZ, C., KEPINSKA, M., MILNEROWICZ, H. and KIZEK, R. 2019. Zinc-modified nanotransporter of anticancer drugs for targeted therapy: biophysical analysis. Journal of nanoscience and nanotechnology [online], 19(5), pages 2483-2488. Available from: https://doi.org/10.1166/jnn.2019.15870

Journal Article Type Article
Acceptance Date Oct 4, 2017
Online Publication Date Dec 18, 2018
Publication Date May 1, 2019
Deposit Date May 21, 2018
Publicly Available Date Mar 29, 2024
Journal Journal of nanoscience and nanotechnology
Print ISSN 1533-4880
Electronic ISSN 1533-4899
Publisher American Scientific Publishers
Peer Reviewed Peer Reviewed
Volume 19
Issue 5
Pages 2483-2488
DOI https://doi.org/10.1166/jnn.2019.15870
Keywords Breast cancer; Chitosan; Doxorubicin; Nanoparticles; Zinc
Public URL http://hdl.handle.net/10059/2930